9.00 a.m. |
Welcome
Matthias Guckenberger, University Hospital Zurich
Michael Weller, University Hospital Zurich |
|
Session 1: Isabell Witzel |
9.10 a.m. |
Novel diagnostic approaches for CNS metastasis
Pieter Wesseling, Amsterdam University Medical Centers, Amsterdam and Princess Máxima Center for Pediatric Oncology, Utecht, The Netherlands |
9.40 a.m. |
Where do we stand with liquid biopsy in CNS metastases?
Anna Bettina Sobottka-Brillout, University Hospital Zurich |
10.10 a.m. |
Coffee Break |
10.30 a.m. |
Insights into the proteomic landscape of brain metastases
Tobias Weiss, University Hospital Zurich |
11.00 a.m. |
Markers of response or hyperprogression to immune checkpoint inhibition
Mitchell Levesque, University Hospital Zurich |
|
Session 2: Nicolaus Andratschke |
11.30 a.m. |
New Challenges and opportunities for neurosurgeons in the management of brain metastasis
Marian Neidert, Cantonal Hospital St. Gallen |
12.00 p.m. |
New challenges and opportunities for Radiation Oncology in the management of brain metastasis
Giuseppe Minniti, University La Sapienza, Rome |
12.30 p.m. |
Lunch Break |
1.30 p.m. |
Controversies from the CNS Metastasis Guideline process: screening, timing of radiotherapy, intrathecal pharmacotherapy
Matthias Preusser, University Hospital Vienna |
2.00 p.m. |
CNS trials at the Comprehensive Cancer Center Zurich
Emilie Le Rhun, University Hospital Zurich |
2.15 p.m. |
Pharmacoscopy for CNS metastasis
Berend Snijder, ETH Zurich |
|
Session 3: Andreas Wicki |
2.30 p.m. |
Blood brain barrier and phrmacokinetic and phase 0 studies
Dieta Brandsma, Netherlands Cancer Institute – Antoni van Leeuwenhoek, Amsterdam |
3.00 p.m. |
Assessing response in CNS metastases trials: the RANO perspective
Lakshmi Nayak, Harvard University, Boston |
3.30 p.m. |
Coffee Break |
3.50 p.m. |
How to integrate brain metastasis into clinical trials: lessons from melanoma
Reinhard Dummer, University Hospital Zurich |
|
Keynote Lecture: Michael Weller |
4.20 p.m. |
Neoadjuvant immunotherapy: a perspective and a vision
Alexander Eggermont, Prinses Máxima Centrum voor Kinderoncologie, Utrecht |
4.50 p.m. |
Wrap-up |